Search filters

List of works by Jürgen Rockstroh

(Mid)West Side Story: Acute Hepatitis C Virus Infection and the Opioid Epidemic in the United States

scientific article published on 20 February 2019

1965. Safety and Efficacy of Glecaprevir/Pibrentasvir in Patients With Chronic Hepatitis C Virus Genotypes 1–6 and Human Immunodeficiency Virus-1 Co-Infection: An Integrated Analysis of Two Phase 3 Clinical Trials

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection ⬇️

scientific article published on April 15, 2013

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine

scientific article published in June 2008

A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results

scientific article published in March 2014

Acute hepatitis C in HIV-positive individuals.

scientific article published on October 2008

Acute hepatitis C infection in HIV-positive patients

scientific article published on February 2011

Adherence to enfuvirtide and its impact on treatment efficacy

scientific article published on February 2008

Administration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinavir

scientific article published on August 1, 2003

Advances in the treatment of HIV/HCV coinfection in adults

scientific article

Alterations of the NK cell pool in HIV/HCV co-infection

scientific article

An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.

scientific article published on 21 January 2014

Antiretroviral treatment of HIV infected patients

scientific article published on 01 April 2003

Antiviral Drugs and the Treatment of Hepatitis C ⬇️

scientific article published on June 1, 2012

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

scientific article

Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe

scientific article

Associations between HIV-RNA-based indicators and virological and clinical outcomes

scientific article published on 5 May 2016

Atazanavir exposure is effective during pregnancy regardless of tenofovir use.

scientific article published on 3 July 2014

Bacteremia caused by a novel helicobacter species in a 28-year-old man with X-linked agammaglobulinemia.

scientific article published on 29 September 2010

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

scientific article published on 31 August 2017

Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study

scientific article published on 8 April 2014

CC-chemokine receptor 5 (CCR5) in hepatitis C--at the crossroads of the antiviral immune response?

scientific article published on 5 May 2004

CD27(+)CD56Bright natural killer cells may be involved in spontaneous clearance of acute hepatitis C in HIV-positive patients.

scientific article published on August 2014

CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.

scientific article published on December 2015

Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort ⬇️

scientific article published on September 9, 2011

Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients

scientific article

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel

scientific article published in April 2002

Care of patients with hepatitis C and HIV co-infection

scientific article

Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial

scientific article published on 22 September 2017

Challenges in the treatment of HIV and HCV coinfection

scientific article

Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART.

scientific article published in March 2004

Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV/HCV coinfection

scientific article

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment

scientific article published on 2 July 2019

Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies ⬇️

scientific article published on July 17, 2011

Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations

scientific article published on May 2004

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d

scientific article published on June 30, 2012

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial

scientific article published in July 2013

Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.

scientific article

Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates

scientific article published in September 2005

Compensatory mutations at the HIV cleavage sites p7/p1 and p1/p6-gag in therapy-naive and therapy-experienced patients.

scientific article published in January 2006

Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+T Regulatory Cells Correlates with Progressive Disease ⬇️

scientific article published on November 3, 2010

Computational methods for the design of effective therapies against drug resistant HIV strains

scientific article

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons

scientific article published on 26 March 2013

Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy

scientific article

Cytokine and Chemokine Signature in Elite Versus Viremic Controllers Infected with HIV.

scientific article

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

scientific article published on 07 September 2016

Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease

scientific article published on 15 November 2016

Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir

scientific article published on 4 March 2010

Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection

scientific article published on 22 November 2017

Differential expansion of T-cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection

scientific article

Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study

scientific article published on December 2005

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

scientific article published on 11 April 2013

Dual treatment of acute HCV infection in HIV co-infection: influence of HCV genotype upon treatment outcome

scientific article published on 19 October 2015

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.

scientific article published in May 2013

Effect of HAART on liver-related mortality in patients with HIV/HCV coinfection

scientific article published in The Lancet

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord

scientific article published on 4 November 2015

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection

scientific article published in November 2003

Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection

scientific article published in January 2008

Effect of coinfection with hepatitis C virus on survival of individuals with HIV-1 infection.

scientific article published on September 2016

Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients

scientific article published on 14 May 2009

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.

scientific article published on January 2009

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.

scientific article published in January 2009

Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study.

scientific article published on 16 March 2018

Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1

scientific article published on 01 February 2007

Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks

scientific article published in May 2002

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

scientific article published on 16 February 2017

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.

scientific article

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

scientific article published on 7 May 2013

Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicent

scientific article published on 18 June 2018

Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Naïve HIV-1–Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK ⬇️

scientific article published on July 1, 2012

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.

scientific article published on 5 October 2005

Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?

scientific article published on July 2017

Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.

scientific article

Evidence for extensive genotypic diversity and recombination of GB virus C (GBV-C) in Germany ⬇️

scientific article published on April 1, 2011

Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men

scientific article

Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy

scientific article

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.

scientific article published on March 2015

Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study)

scientific article

Fifteen years of env C2V3C3 evolution in six individuals infected clonally with human immunodeficiency virus type 1.

scientific article published on November 2007

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

scientific article published in June 2002

Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml

scientific article published on 01 October 2007

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption

scientific article

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany

scientific article

Future of hepatitis C therapy: development of direct-acting antivirals

scientific article

GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells

scientific article published on January 2010

HAART-update for the general practitioner

scientific article published on 01 May 2011

HCV healing also in HIV infected patients

scientific article published on June 2017

HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

scientific article published on 17 September 2016

HIV and Cancer in Germany ⬇️

scientific article published on February 25, 2011

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective

scientific article

HIV and hepatitis C coinfection

scientific article published in November 2011

HIV and sports: good or evil?

scientific article published on June 2016

HIV and the liver.

scientific article published in March 2009

HIV mono-infection is associated with an impaired anti-hepatitis C virus activity of natural killer cells

scientific article

HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany

scientific article published on 02 April 2011

HIV protease inhibitors in combination with boceprevir: are drug-drug interactions the same for all patients?

scientific article published on September 2012

HIV provider-patient communication regarding cardiovascular risk: results from the AIDS Treatment for Life International Survey

scientific article

HIV provider-patient communication regarding cardiovascular risk: results from the AIDS Treatment for Life International Survey

scientific article published on July 2014

HIV resistance testing and detected drug resistance in Europe

scientific article published on July 2015

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

scientific article published on 3 June 2019

HIV treatment adherence, patient health literacy, and health care provider-patient communication: results from the 2010 AIDS Treatment for Life International Survey

scientific article published on 23 February 2012

HIV-HCV co-infection facing HCV protease inhibitor licensing: implications for clinicians

scientific article published on 17 April 2012

HIV-related stigma within communities of gay men: a literature review

scientific article

HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults

scientific article

HepHIV2019 Bucharest Conference: challenges of timely and integrated testing and care

article

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis

scientific article published on 22 October 2012

Hepatic profile analyses of tipranavir in Phase II and III clinical trials

scientific article

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection

scientific article

Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.

scientific article published in January 2011

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?

scientific article

Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression

scientific article published on April 2009

Hepatitis C virus reinfection-more to come?

scientific article published on 23 December 2016

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

scientific article published on September 2012

Hepatitis C-associated autoimmunity in patients coinfected with HIV.

scientific article

Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays

scientific article

Hepatotoxicity and liver disease in the context of HIV therapy

scientific article published on July 2007

Highlights of the International Congress on Drug Therapy in HIV Infection, 23-26 October 2016, Glasgow, UK.

scientific article published on April 2017

Highlights of the third international workshop on HIV and hepatitis coinfection

scientific article published in October 2007

Highly active antiretroviral therapy in HIV and hepatitis C coinfected individuals: friend or foe?

scientific article

Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study

scientific article

Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

scientific article

Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries

scientific article published on January 2014

Impact of Baseline Antiretroviral Resistance Status on Efficacy Outcomes Among Patients Receiving Maraviroc Plus Optimized Background Therapy in the MOTIVATE 1 and 2 Trials ⬇️

scientific article published on May 1, 2010

Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients

scientific article published on 14 February 2008

Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.

scientific article published on 9 May 2013

Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients

scientific article published on 06 November 2012

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study

scientific article published on 8 December 2003

Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection

scientific article published in December 2003

Influence of endurance training and marathon running on red cell deformability in HIV patients

scientific article

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

scientific article

Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection

scientific article published on July 2009

Integrase inhibitors: why do we need a new drug class for HIV therapy?

scientific article

Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals

scientific article

Interview with Professor Jürgen Rockstroh, director of the Bonn University Clinic. Atazanavir in general practice

scientific article published in April 2004

Introduction to late presentation for HIV treatment in Europe

scientific article published in January 2010

Investigation of Efavirenz Discontinuation in Multi-ethnic Populations of HIV-positive Individuals by Genetic Analysis

scientific article

Is there a need for liver disease monitoring in HIV patients in Africa?

scientific article published on January 2011

Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?

scientific article published on 01 December 2005

Late presentation of chronic viral hepatitis for medical care: a consensus definition

scientific article

Latent infection of human bocavirus accompanied by flare of chronic cough, fatigue and episodes of viral replication in an immunocompetent adult patient, Cologne, Germany

scientific article published on 30 August 2016

Ledipasvir-sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial

scientific article published on March 2017

Limited but increasing use of treatment for hepatitis C across Europe in patients coinfected with HIV and hepatitis C

article

Liver Cirrhosis as a Risk Factor for Direct-Acting Antiviral Therapy Failure in Real-Life Hepatitis C Virus/Human Immunodeficiency Virus Coinfection

scientific article published on 27 July 2017

Liver Fibrosis in HIV Patients Receiving a Modern cART: Which Factors Play a Role?

scientific article published on December 2015

Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation

scientific article published on May 2009

Liver fibrosis in HIV: which role does HIV itself, long-term drug toxicities and metabolic changes play?

scientific article published on July 2014

Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals

scientific article published on 7 December 2011

Liver histopathology in human immunodeficiency virus-hepatitis C virus co-infected patients with fatal liver disease

scientific article

Living donor liver transplant from an HIV-positive individual to an HIV-negative individual: could this become a new reality?

article

Long-term benzimidazole treatment of alveolar echinococcosis with hematogenic subcutaneous and bone dissemination

scientific article published on 5 March 2003

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

scientific article published in February 2010

Long-term treatment with raltegravir or efavirenz combined with tenofovir/emtricitabine for treatment-naive human immunodeficiency virus-1-infected patients: 156-week results from STARTMRK.

scientific article published in October 2011

Lopinavir/ritonavir plus saquinavir in salvage therapy; pharmacokinetics, tolerability and efficacy

scientific article

Management of hepatitis C/HIV coinfection

scientific article

Management of late-presenting patients with HIV infection

scientific article published on January 2010

Managing HCV infection: present and future

scientific article published on 23 May 2014

Managing HIV/hepatitis C co-infection in the era of direct acting antivirals

scientific article

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Wee

scientific article published on 5 April 2016

Maraviroc, risks and benefits: a review of the clinical literature

scientific article published on 01 September 2008

Moderate endurance training (marathon-training) - effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project.

scientific article published on 08 August 2017

Natural history and management of hepatitis C: does sex play a role?

scientific article published on July 2014

Natural history of liver disease and effect of hepatitis C virus on HIV disease progression

scientific article published on September 2015

Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals

scientific article published on 6 March 2009

New drugs for HIV therapy

scientific article published on 01 December 2005

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

article

Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study

scientific article published in December 2008

Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals

scientific article published on January 2015

PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension

scientific article

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

scientific article

Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.

scientific article published in January 2006

Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients.

scientific article published in January 2007

Phase 3 Randomized, Controlled Trial of Switching to Fixed-dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adults: Week 48 Results.

scientific article published on 4 October 2017

Phospholipid autoantibodies and the antiphospholipid antibody syndrome: diagnostic accuracy of 23 methods studied by variation in ROC curves with number of clinical manifestations

scientific article published on 01 July 2002

Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany

scientific article published on 12 July 2010

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

scientific article published on 13 December 2011

Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements

scientific article

Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies.

scientific article published in January 2008

Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death

scientific article

Pulmonary sarcoidosis shortly after spinal tuberculosis infection: a diagnostic challenge

scientific article published on 11 April 2014

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

scientific article published on 18 September 2011

Raltegravir with optimized background therapy for resistant HIV-1 infection

scientific article

Rapid determination of the Delta32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by lightcycler real-time polymerase chain reaction

scientific article

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

scientific article published in PLoS ONE

Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection

scientific article published on 20 May 2002

Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study

scientific article

Regional differences in self-reported HIV care and management in the EuroSIDA study

scientific article published on 2 November 2014

Regulation of CC chemokine receptor 5 in hepatitis G virus infection

scientific article published in July 2003

Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation

scientific article published on 01 January 2010

Risk factors associated with older age in treatment-naive HIV-positive patients

scientific article published on 24 January 2012

Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.

scientific article published in January 2007

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.

scientific article published on 22 July 2017

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial

scientific article

Safety of lopinavir/ritonavir for the treatment of HIV-infection

scientific article

Second European Round Table on the Future Management of HIV: 10-11 October 2014, Barcelona, Spain

scientific article published on July 2015

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

scientific article

Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level

scientific article

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).

scientific article

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

scientific article published on 4 February 2015

Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study

scientific article published on 8 October 2012

State-of-the-art classification and multimodality treatment of malignant thymoma ⬇️

scientific article published on January 13, 2012

Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy

scientific article published on 17 December 2013

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

scientific article published in July 2008

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study

scientific article published on March 2017

Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme

scientific article

Telaprevir-containing triple therapy in acute HCV coinfection: The CHAT Study

scientific article

The ARRIBA concept: adequate resorption of ribavirin

scientific article published on 19 January 2015

The Dose-Response Relationship of Peginterferon Alfa-2a and Ribavirin in the Treatment of Patients Coinfected with HIV-HCV ⬇️

scientific article published on January 1, 2012

The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients

scientific article published on 24 May 2007

The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells.

scientific article published on November 2009

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

scientific article published on 9 July 2018

The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations

The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection.

scientific article published in August 2010

The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.

scientific article published on November 2013

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women ⬇️

scientific article published on March 13, 2013

The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS

scientific article published on 01 April 2003

The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.

scientific article published in July 2008

The treatment of chronic hepatitis C virus infection in HIV co-infection

scientific article published on January 2009

The way forward in HCV treatment--finding the right path

scientific article

Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference

scientific article

Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort

scientific article published in January 2010

Treatment of acute hepatitis C in HIV coinfection: Is this a chance for achieving microelimination?

article

Treatment of acute hepatitis C in HIV infection

scientific article

Treatment of acute hepatitis C in HIV-positive individuals: what are the challenges?

scientific article published on March 2009

Treatment of acute hepatitis C infection in HIV-infected patients ⬇️

scientific article published on July 1, 2011

Treatment of chronic HCV genotype 1 coinfection

scientific article published on 31 July 2015

Treatment options of AIDS-related lymphoma

scientific article

Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study

scientific article published on 15 June 2016

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients

scientific article

Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study

scientific article

Uptake of HCV treatment in HIV/HCV coinfected patients across europe in the era of direct-acting antivirals

article

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

article

Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study

scientific article

Variant of hepatitis B virus with primary resistance to adefovir

scientific article published in April 2006

[Treatment of HPV-associated Anal Lesions in HIV-positive Patients - Comparison of Surgical Treatment and Topical Therapy with Imiquimod]

scientific article published on 03 July 2018

microRNA-200a: A stage-dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients.

scientific article published on 27 February 2017

Paulina is supported by:

About Paulina

Help